Comparison of DNA synthesis in white and brown adipose tissue in rats with ventromedial hypothalamic lesions.
Ventromedial hypothalamic (VMH) lesions cause excessive fat accumulation in white adipose tissue (WAT), and brown adipose tissue (BAT); however, little information is available on whether or not cell proliferation occurs in WAT and BAT after VMH lesioning. In this study, we determined the DNA content and thymidine incorporation in unilateral parametrial WAT and interscapular BAT 0, 1, 3, and 7 days after VMH lesioning, and examined the mechanism of increased DNA content in WAT. In rats with VMH lesions, the weight of WAT and BAT had increased significantly at 7 days, and the DNA content and thymidine incorporation of WAT had increased significantly at 3 days and continued to increase for up to 7 days, while those of BAT did not increase for as long as 7 days after VMH lesioning. Restricted food intake according to the pair-feeding method partially inhibited the increased DNA content in WAT. The increased DNA content in WAT was mostly restored but not completely by the administration of anti-insulin antibody, and by administration of propranolol, a beta-adrenergic blocker. The results demonstrated that VMH lesions induced DNA synthesis in WAT early after VMH lesioning, but did not induce DNA synthesis in BAT, and suggested that either hyperinsulinemia or a beta-adrenergic receptor mechanism or both may be responsible for the increased DNA content in WAT.
Kiba
T
T
Third Department of Internal Medicine, Yokohama City University, School of Medicine, Japan.
Tanaka
K
K
Hoshino
M
M
Numata
K
K
Inoue
S
S
D000273:Adipose Tissue / Q000378:metabolism*; D002001:Adipose Tissue, Brown / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001835:Body Weight / Q000502:physiology; D004247:DNA / Q000096:biosynthesis* / Q000378:metabolism; D005247:Feeding Behavior / Q000502:physiology; D005260:Female; D007330:Insulin Antibodies / Q000276:immunology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013936:Thymidine / Q000494:pharmacology; D014697:Ventromedial Hypothalamic Nucleus / Q000502:physiology*
D007330:Insulin Antibodies; D001285:Atropine; D004247:DNA; D011433:Propranolol; D013936:Thymidine; D010646:Phentolamine